A new immunochemical strategy for triple-negative breast cancer therapy

Triple-negative breast cancer (TNBC) is a highly diverse group of malignant neoplasms which tend to have poor outcomes, and the development of new targets and strategies to treat these cancers is sorely needed. Antibody–drug conjugate (ADC) therapy has been shown to be a promising targeted therapy f...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Chih-Wei, Zheng, Tianqing, Grande, Geramie, Nanna, Alex R., Rader, Christoph, Lerner, Richard A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295383/
https://www.ncbi.nlm.nih.gov/pubmed/34290315
http://dx.doi.org/10.1038/s41598-021-94230-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295383/
https://www.ncbi.nlm.nih.gov/pubmed/34290315
http://dx.doi.org/10.1038/s41598-021-94230-4

Ejemplares similares